GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » DeferredTaxAndRevenue

China Isotope & Radiation (HKSE:01763) DeferredTaxAndRevenue : HK$0 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

China Isotope & Radiation's current deferred tax and revenue for the quarter that ended in Dec. 2023 was HK$0 Mil.

China Isotope & Radiation DeferredTaxAndRevenue Historical Data

The historical data trend for China Isotope & Radiation's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation DeferredTaxAndRevenue Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only - - - - -

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China Isotope & Radiation DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Ubs Group Ag 2201 Interest of corporation controlled by you
Li Hongbo 2201 Interest of corporation controlled by you
Lianwen Ltd 2101 Beneficial owner
Invesco Advisers, Inc. 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Invesco Hong Kong Limited 2102 Investment manager
Invesco Corporate Class Inc. 2106 Person having a security interest in shares
M&g Plc 2201 Interest of corporation controlled by you
Shanghai Industrial Holdings Limited 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Serenity Investment Master Fund Limited 2101 Beneficial owner
Serenity Capital Management, Ltd. 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd. 2201 Interest of corporation controlled by you
S.i. Infrastructure Holdings Limited 2201 Interest of corporation controlled by you

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines